2022-2029 年肺炎藥物全球市場規模研究與預測，按藥物、分銷渠道、年齡組、地區分析

2021 年全球肺炎藥物市場價值約為 132.4 億美元，預計在 2022-2029 年預測期內將以超過 8.5% 的健康增長率增長。

肺炎是一種急性呼吸道感染，會導致由細菌、病毒或真菌引起的一個或兩個肺部氣囊發炎。肺炎的症狀包括咳嗽時伴有綠色、黃色、帶血的粘液、發燒、出汗、呼吸急促、呼吸急促而淺，以及胸口刺痛。肺炎病例數量的增加、未滿足的需求增加以及主要參與者的戰略舉措是推動市場增長的主要因素。

根據聯合國兒童基金會的數據 - 截至 2019 年，全球每年約有 700,000 名五歲以下兒童死亡，每天約有 2,000 人死亡。南亞也是受影響最嚴重的地區（每 100,000 名兒童 2,500 例），其次是西非和中非（每 100,000 名兒童 1,620 例）。此外，由於新興國家的醫療費用上漲以及製藥領域的積極研發活動，預計該市場在預測期內將大幅增長。然而，高昂的治療成本和缺乏對預防疫苗的認識將阻礙整個 2022-2029 年預測期內的市場增長。

全球肺炎藥物市場研究中考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。由於大型製藥公司的存在以及該地區強大的醫療基礎設施的可用性，北美已成為收入方面的關鍵地區。另一方面，由於老年人口增加和小兒肺炎增加等因素，預計亞太地區在預測期內將顯著增長。

本報告中包含的主要市場參與者包括：

• Abbott Laboratories
• Bayer AG
• Eli Lilly & Company
• GlaxoSmithKline PLC.
• Lupin Pharmaceuticals, Inc.
• Merck KGAA
• Novartis AG
• Pfizer, Inc.
• Sanofi S.A.
• Teva Pharmaceuticals Industries Limited.

市場的最新發展。

• 2020 年 12 月，總部位於印度的印度血清研究所推出了第一種本土肺炎疫苗。這種新疫苗將在聯合國兒童基金會網絡的幫助下提供給世界各地的兒童。
• 2021 年 7 月，美國默克公司在 18 歲及以上的成年人中鑑定出肺炎球菌血清型 1、3、4、5、6A、6B、7F、9V、14、18C、19A、19F、22F 和 23F . 已獲得美國食品和藥物管理局 (FDA) 批准用於預防 33F 特異性侵襲性疾病的新型 VAXNEUVANCE□（肺炎球菌 15 價結合疫苗）。

全球肺炎藥物市場研究範圍。

歷史數據：2019-2020-2021

基本估計年份：2021

預測期間：2022-2029

報告涵蓋的收入預測、公司排名、競爭格局、增長因素、趨勢

目標細分治療藥物、分銷渠道、年齡組、地區

區域範圍北美、歐洲、亞太地區、拉丁美洲、世界其他地區

購買後可免費定制覆蓋率報告（最多 8 小時的分析師工作）。添加或更改國家、地區、細分範圍*

這項研究的目的是定義近年來各個細分市場和國家的市場規模，並預測他們在未來幾年的價值。該報告旨在捕捉被調查國家工業的定性和定量方面。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。此外，它還包含供利益相關者投資的微觀市場潛在機會，以及對主要參與者的競爭格局和產品供應的深入分析。市場的詳細細分和子細分如下所述。

按藥物

預防疫苗

治療

按銷售渠道

醫院

藥品分銷商

雜項

按年齡段

兒科

成人

老年

按地區

北美

美國

加拿大

歐洲

英國

德國

法國

西班牙

意大利

其他歐洲

亞太地區

中國

印度

日本

澳大利亞

韓國

其他亞太地區

拉丁美洲

巴西

墨西哥

世界其他地區

內容

第 1 章執行摘要

• 市場概況
• 2019-2029 年各細分市場的全球市場估計和預測
  • 肺炎藥物市場（按地區）：2019-2029
  • 肺炎藥物市場（按藥物分類）：2019-2029
  • 肺炎藥物市場（按分銷渠道）：2019-2029
  • 肺炎藥物市場（按年齡組）：2019-2029
• 主要趨勢
• 調查方法
• 調查先決條件

第2章肺炎藥物的全球市場定義和範圍

• 調查的目的
• 市場定義和範圍
  • 調查範圍
  • 工業發展
• 調查年份
• 貨幣兌換率

第三章全球肺炎藥物市場動態

• 肺炎藥品市場影響分析（2019-2029）
  • 市場驅動因素
    • 肺炎病例增加
    • 不斷增長的未滿足需求
    • 主要市場參與者的戰略舉措
  • 市場挑戰
    • 高昂的治療費用
    • 缺乏對預防疫苗的認識
  • 市場機會
    • 發展中地區的醫療支出增加
    • 在製藥領域開展研發活動

第四章肺炎藥物全球市場行業分析

• 波特 5 力模型
  • 供應商的議價能力
  • 買家的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭公司之間的敵對關係
• 波特 5 力模型的未來方法 (2019-2029)
• 害蟲分析
  • 政治
  • 經濟的
  • 社交
  • 技術
• 投資招聘模式
• 分析師的結論和建議
• 頂級投資機會
• 關鍵成功策略

第 5 章風險評估：COVID-19 的影響

• 評估 COVID-19 對行業的總體影響
• COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球肺炎藥物市場，按藥物分類

• 市場概況
• 全球肺炎藥物市場：按藥物、性能-潛力分析
• 2019-2029 年全球肺炎藥物市場、按藥物分類的估計和預測
• 肺炎藥物市場，細分市場分析
  • 預防性疫苗
  • 治療藥物

第 7 章：肺炎藥物的全球市場：按分銷渠道分類

• 市場概況
• 肺炎藥物的全球市場：按分銷渠道進行的性能潛力分析
• 2019-2029 年全球肺炎藥物市場，按分銷渠道估計和預測
• 肺炎藥物市場，細分市場分析
  • 醫院
  • 藥店
  • 其他

第 8 章全球肺炎藥物市場：按年齡組分類

• 市場概況
• 肺炎藥物的全球市場：按年齡組劃分），性能潛力分析
• 按年齡組劃分的肺炎藥物全球市場、估計和預測 (2019-2029)
• 肺炎藥物市場，細分市場分析
  • 兒科
  • 成人
  • 年老

第 9 章全球肺炎藥物市場：區域分析

• 肺炎藥物市場，按地區劃分的市場概況
• 北美
  • 美國
    • 2019-2029 年各治療藥物的估計和預測
    • 2019-2029 年各分銷渠道的估計和預測
    • 2019-2029 年各年齡段的估計和預測
  • 加拿大
• 歐洲肺炎藥物市場概況
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 意大利
  • 其他歐洲地區
• 亞太肺炎藥物市場概況
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 韓國
  • 其他亞太地區
• 拉丁美洲的肺炎藥物市場概況
  • 巴西
  • 墨西哥
• 世界其他地區

第 10 章衝突信息

• 頂級市場策略
• 公司簡介
  • 雅培實驗室
    • 主要信息
    • 概覽
    • 財務（如果有數據）
    • 產品概覽
    • 近期發展狀況
  • Bayer AG
  • Eli Lilly & Company
  • GlaxoSmithKline PLC.
  • Lupin Pharmaceuticals, Inc.
  • Merck KGAA
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi S.A.
  • Teva Pharmaceuticals Industries Limited.

第 11 章研究過程

• 研究過程
  • 數據挖掘
  • 分析
  • 市場評估
  • 驗證
  • 出版
• 調查屬性
• 調查先決條件

Global Pneumonia Therapeutics Market is valued approximately USD 13.24 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2022-2029. Pneumonia is a type of acute respiratory infection that inflames the air sacs in one or both lungs caused by bacteria, viruses, or fungi. The signs and symptoms of Pneumonia include cough, with greenish, yellow, and bloody mucus, fever, sweating, shortness of breath, rapid, shallow breathing, and stabbing chest pain among others. The increasing incidences of pneumonia and growing unmet clinical needs as well as strategic initiatives from leading market players are key factors accelerating the market growth.

According to UNICEF - as of 2019, globally around 700,000 children under five lost their lives every year, accounting for around 2,000 deaths every day. In addition, South Asia (2,500 cases per 100,000 children) is the most affected region followed by West and Central Africa (1,620 cases per 100,000 children). Also, rising healthcare spending in developing regions and growing number of R&D activities in pharmaceuticals sector would create lucrative growth prospectus for the market over the forecast period. However, a high treatment cost and lack of awareness towards preventive vaccines impede the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Pneumonia Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region in terms of revenue due to presence of leading pharmaceutical giants as well as availability of robust healthcare infrastructure in the region. Whereas Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric population and increasing prevalence of pneumonia in children in the region.

Major market players included in this report are:

Abbott Laboratories

Bayer AG

Eli Lilly & Company

GlaxoSmithKline PLC.

Lupin Pharmaceuticals, Inc.

Merck KGAA

Novartis AG

Pfizer, Inc.

Sanofi S.A.

Teva Pharmaceuticals Industries Limited.

Recent Developments in the Market:

• In December 2020, India based Serum Institute of India launched first indigenous vaccine for pneumonia. The new vaccines would be provided for children throughout the world with the help of UNICEF network.
• In July 2021, US based Merck received the U.S. Food and Drug Administration (FDA) approval for its new VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) intended for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in adults 18 years of age and older.

Global Pneumonia Therapeutics Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered Therapeutics, Distribution Channel, Age Group, Region

Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapeutics

Prevention Vaccines

Treatment Drugs

By Distribution Channel

Hospitals

Pharmaceutical Stores

Other

By Age Group

Pediatric

Adult

Geriatric

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Pneumonia Therapeutics Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Pneumonia Therapeutics Market, by Therapeutics, 2019-2029 (USD Billion)
  • 1.2.3. Pneumonia Therapeutics Market, by Distribution Channel, 2019-2029 (USD Billion)
  • 1.2.4. Pneumonia Therapeutics Market, by Age Group, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Pneumonia Therapeutics Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Pneumonia Therapeutics Market Dynamics

• 3.1. Pneumonia Therapeutics Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing incidences of Pneumonia
    • 3.1.1.2. Growing unmet clinical needs
    • 3.1.1.3. Strategic initiatives from leading market players.
  • 3.1.2. Market Challenges
    • 3.1.2.1. High treatment cost.
    • 3.1.2.2. Lack of awareness towards preventive vaccines.
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising healthcare spending in developing regions.
    • 3.1.3.2. Growing number of R&D activities in pharmaceuticals sector.

Chapter 4. Global Pneumonia Therapeutics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Pneumonia Therapeutics Market, by Therapeutics

• 6.1. Market Snapshot
• 6.2. Global Pneumonia Therapeutics Market by Therapeutics, Performance - Potential Analysis
• 6.3. Global Pneumonia Therapeutics Market Estimates & Forecasts by Therapeutics 2019-2029 (USD Billion)
• 6.4. Pneumonia Therapeutics Market, Sub Segment Analysis
  • 6.4.1. Prevention Vaccines
  • 6.4.2. Treatment Drugs

Chapter 7. Global Pneumonia Therapeutics Market, by Distribution Channel

• 7.1. Market Snapshot
• 7.2. Global Pneumonia Therapeutics Market by Distribution Channel, Performance - Potential Analysis
• 7.3. Global Pneumonia Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
• 7.4. Pneumonia Therapeutics Market, Sub Segment Analysis
  • 7.4.1. Hospitals
  • 7.4.2. Pharmaceutical Stores
  • 7.4.3. Others

Chapter 8. Global Pneumonia Therapeutics Market, by Age Group

• 8.1. Market Snapshot
• 8.2. Global Pneumonia Therapeutics Market by Age Group, Performance - Potential Analysis
• 8.3. Global Pneumonia Therapeutics Market Estimates & Forecasts by Age Group 2019-2029 (USD Billion)
• 8.4. Pneumonia Therapeutics Market, Sub Segment Analysis
  • 8.4.1. Pediatric
  • 8.4.2. Adult
  • 8.4.3. Geriatric

Chapter 9. Global Pneumonia Therapeutics Market, Regional Analysis

• 9.1. Pneumonia Therapeutics Market, Regional Market Snapshot
• 9.2. North America Pneumonia Therapeutics Market
  • 9.2.1. U.S. Pneumonia Therapeutics Market
    • 9.2.1.1. Therapeutics breakdown estimates & forecasts, 2019-2029
    • 9.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.1.3. Age Group breakdown estimates & forecasts, 2019-2029
  • 9.2.2. Canada Pneumonia Therapeutics Market
• 9.3. Europe Pneumonia Therapeutics Market Snapshot
  • 9.3.1. U.K. Pneumonia Therapeutics Market
  • 9.3.2. Germany Pneumonia Therapeutics Market
  • 9.3.3. France Pneumonia Therapeutics Market
  • 9.3.4. Spain Pneumonia Therapeutics Market
  • 9.3.5. Italy Pneumonia Therapeutics Market
  • 9.3.6. Rest of Europe Pneumonia Therapeutics Market
• 9.4. Asia-Pacific Pneumonia Therapeutics Market Snapshot
  • 9.4.1. China Pneumonia Therapeutics Market
  • 9.4.2. India Pneumonia Therapeutics Market
  • 9.4.3. Japan Pneumonia Therapeutics Market
  • 9.4.4. Australia Pneumonia Therapeutics Market
  • 9.4.5. South Korea Pneumonia Therapeutics Market
  • 9.4.6. Rest of Asia Pacific Pneumonia Therapeutics Market
• 9.5. Latin America Pneumonia Therapeutics Market Snapshot
  • 9.5.1. Brazil Pneumonia Therapeutics Market
  • 9.5.2. Mexico Pneumonia Therapeutics Market
• 9.6. Rest of The World Pneumonia Therapeutics Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Abbott Laboratories
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Bayer AG
  • 10.2.3. Eli Lilly & Company
  • 10.2.4. GlaxoSmithKline PLC.
  • 10.2.5. Lupin Pharmaceuticals, Inc.
  • 10.2.6. Merck KGAA
  • 10.2.7. Novartis AG
  • 10.2.8. Pfizer, Inc.
  • 10.2.9. Sanofi S.A.
  • 10.2.10. Teva Pharmaceuticals Industries Limited.

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Pneumonia Therapeutics Market, report scope
• TABLE 2. Global Pneumonia Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Pneumonia Therapeutics Market estimates & forecasts by Therapeutics 2019-2029 (USD Billion)
• TABLE 4. Global Pneumonia Therapeutics Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
• TABLE 5. Global Pneumonia Therapeutics Market estimates & forecasts by Age Group 2019-2029 (USD Billion)
• TABLE 6. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 17. U.S. Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. U.S. Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. Canada Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 20. Canada Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. Canada Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. UK Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 23. UK Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. UK Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 25. Germany Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 26. Germany Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. Germany Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 28. France Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 29. France Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. France Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 31. Italy Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 32. Italy Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Italy Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 34. Spain Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 35. Spain Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. Spain Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 37. RoE Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 38. RoE Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. RoE Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 40. China Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 41. China Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. China Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 43. India Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 44. India Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. India Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 46. Japan Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 47. Japan Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. Japan Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 49. South Korea Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 50. South Korea Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. South Korea Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 52. Australia Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 53. Australia Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. Australia Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. RoAPAC Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 58. Brazil Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 59. Brazil Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Brazil Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 61. Mexico Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 62. Mexico Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. Mexico Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 64. RoLA Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 65. RoLA Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. RoLA Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 67. Row Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 68. Row Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. Row Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 70. List of secondary sources, used in the study of global Pneumonia Therapeutics Market
• TABLE 71. List of primary sources, used in the study of global Pneumonia Therapeutics Market
• TABLE 72. Years considered for the study
• TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Pneumonia Therapeutics Market, research methodology
• FIG 2. Global Pneumonia Therapeutics Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Pneumonia Therapeutics Market, key trends 2021
• FIG 5. Global Pneumonia Therapeutics Market, growth prospects 2022-2029
• FIG 6. Global Pneumonia Therapeutics Market, porters 5 force model
• FIG 7. Global Pneumonia Therapeutics Market, pest analysis
• FIG 8. Global Pneumonia Therapeutics Market, value chain analysis
• FIG 9. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Pneumonia Therapeutics Market, regional snapshot 2019 & 2029
• FIG 15. North America Pneumonia Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Pneumonia Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Pneumonia Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Pneumonia Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 19. Global Pneumonia Therapeutics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable